<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02618005</url>
  </required_header>
  <id_info>
    <org_study_id>Probiotics</org_study_id>
    <nct_id>NCT02618005</nct_id>
  </id_info>
  <brief_title>Probiotics on Immune Function and Intestinal Microbiota in Astronauts Under Closed Microgravity Environment</brief_title>
  <official_title>Study for Evaluating the Impact of Continuous Consumption of Probiotics on Immune Function and Intestinal Microbiota in Astronauts Under Closed Microgravity Environment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yakult Honsha Co., LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Japan Aerospace Exploration Agency</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yakult Honsha Co., LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human immune function and intestinal microbiota are suggested to be altered within
      long-duration stay in space. Accumulated evidences on earth support that Lactobacillus casei
      strain Shirota (LcS) is a promising probiotic strain on improvement of immune function and
      intestinal microbiota. This study aims to investigate the impact of long-duration spaceflight
      as well as intake of LcS on the international space station (ISS), on immune system and
      intestinal microbiota in astronauts.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>October 2015</start_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Longitudinal changes in the number of LcS in feces</measure>
    <time_frame>9-18 months</time_frame>
    <description>Number of LcS in feces will be assessed by PMA-qPCR, during pre-flight, in-flight and post-flight.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Longitudinal changes in the level of immune markers</measure>
    <time_frame>9-18 months</time_frame>
    <description>Levels of immune markers in blood/saliva will be assessed by ELISA and bioassay, during pre-flight, in-flight and post-flight.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Longitudinal changes in numbers and composition of intestinal microbiota</measure>
    <time_frame>9-18 months</time_frame>
    <description>Numbers and composition of bacteria in feces will be assessed by RT-qPCR/qPCR and next generation sequencer analysis, during pre-flight, in-flight and post-flight.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Immune Function and Intestinal Microbiota</condition>
  <arm_group>
    <arm_group_label>LcS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consuming probiotic capsule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic capsule</intervention_name>
    <description>Continuously take five capsules containing freeze-dried LcS on ISS for four weeks, from four weeks before the return (R-4W) to one day before the return (R-1d)</description>
    <arm_group_label>LcS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals who are scheduled to stay on the ISS for at least 3 months

          -  Individuals who fully understand the study protocol and provide written informed
             consent for the study participation

        Exclusion Criteria:

          -  Individuals who routinely use antibiotic, laxative, and/or bowel regulating medicine

          -  Individuals who participate in other research that competes with this study in terms
             of the purpose and field, e.g., study with dietary management or intake of
             bifidobacteria/lactic acid bacteria, oligosaccharides, antibiotic, laxative, and/or
             bowel regulating medicine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Japan Aerospace Exploration Agency</name>
      <address>
        <city>Ibaraki</city>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2015</study_first_submitted>
  <study_first_submitted_qc>November 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2015</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Astronauts</keyword>
  <keyword>Probiotics</keyword>
  <keyword>Immune function</keyword>
  <keyword>Intestinal microbiota</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

